Next Generation Molecular Assay Market Market Analysis

Technique (Enzyme-Linked Immuno-Sorbent Assay, Gene Expression Profiling Assays, Polymerase Chain Reaction)

By the end of 2036, polymerase chain reaction segment is expected to dominate around ~41% next generation molecular assay market share. PCR assay plays a fundamental role in sequencing as the methods for sequence-ready NGS libraries involve PCR steps, making it a useful and effective technique for next generation molecular assay. When a PCR test was performed on brucellosis (a zoonotic disease) for rapid diagnosis, the results obtained showed that 7% of cases had positive PCR. Moreover, PCR assays are considered to be more accurate than serological tests and blood culture techniques.

Application (Hospital, Pharmaceutical Companies, Biotech Companies)

Pharmaceutical segment in the next generation molecular assay market is set to exhibit CAGR of around 6% from 2024 to 2036. PCR and ELISA when combined help in the identification of challenging disease agents where clinical signs are not visible and are also used in the R&D of new vaccines and drugs by pharmaceutical companies.ELISA test is performed to detect blood-borne diseases such as HIV.

Our in-depth analysis of the market includes the following segments:

Technique	Enzyme Linked Immuno- Sorbent Assays Gene Expression Profiling Assay Polymerase Chain Reaction
Application	Hospital Pharmaceutical Companies Biotech Companies
Type	Virus testing HPV testing HIV testing Influenza testing HCV testing Blood Testing Genetic Testing Oncological Testing STD Testing

Frequently Asked Questions (FAQ)

In the year 2023, the industry size of the next generation molecular assay was over USD 5 billion.

The market size for next generation molecular assay is projected to cross USD 9 billion by the end of 2036 expanding at a CAGR of 5% during the forecast period i.e., between 2024-2036.

The major players in the market are Thermo Fisher Scientific Inc., Bio-rad Laboratories, Inc., Qiagen, Illumina, Charles River Laboratories, and others.

In terms of type, the polymerase chain reaction segment is anticipated to account for the largest market share of % during 2024-2036.

The North America next generation molecular assay sector is poised to hold the highest share of 40% by 2036.

Next Generation Molecular Assay Market Market Analysis